The aim is to evaluate the effectiveness of different influenza vaccine formulations in older adults undergoing maintenance hemodialysis.
Comparison of high-dose, cell culture-based, and standard-dose vaccines.
Focus on older adults receiving maintenance hemodialysis.
High-dose and cell culture-based vaccines provide modestly increased protection compared to standard-dose vaccines.
Findings indicate that vaccine formulation may influence immunity in this population.
Abstract
Among older adults undergoing dialysis, high-dose vaccine and cell culture-based vaccine may provide modestly increased protection versus standard-dose vaccine.